Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?

Abstract

The t(14;18)(q32;q21) translocation is closely associated with follicular lymphoma (FL), and is routinely assessed with molecular methods exploring BCL2 breakpoints for both diagnosis and minimal residual disease (MRD) monitoring. We and others have previously reported new recurrent breakpoints (3′BCL2 and 5′mcr) which could be easily analyzed. In this study, we characterized the BCL2 breakpoints in 113 untreated patients with t(14;18)-positive FL and correlated their location with the location of JH break and with the clinical features. Breakpoints were respectively located at the major breakpoint region (MBR) in 73 cases (65%), at the minor cluster region (mcr) in 10 cases (9%), at 3′BCL2 in 14 cases (12%) and at 5′mcr in seven cases (6%). Finally, the breakpoint could not be located in nine patients (8%). 5′mcr cases were associated with bulky and high-stage disease, with frequent extranodal involvement and bone marrow infiltration. Survival studies did not show any correlation between breakpoint location and clinical outcome. The joining JH6 segment was the most frequently involved whatever the breakpoint location. In conclusion, unusual BCL2 breakpoints are found in about 20% of newly diagnosed follicular lymphomas and their study should be considered in the investigation of BCL2-JH rearrangement. It was not possible, in this series, to demonstrate any correlation between breakpoint location and either initial characteristics of the disease or survival of the patients.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M . Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer N Engl J Med 1987 316: 79–84

    Article  CAS  PubMed  Google Scholar 

  2. Bordeleau L, Berinstein NL . Molecular diagnostics in follicular non-Hodgkin's lymphoma: a review Semin Oncol 2000 27: 42–52

    CAS  PubMed  Google Scholar 

  3. Tsujimoto Y, Cossman J, Jaffe E, Croce CM . Involvement of the bcl-2 gene in human follicular lymphoma Science 1985 228: 1440–1443

    Article  CAS  PubMed  Google Scholar 

  4. Cleary ML, Galili N, Sklar J . Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas J Exp Med 1986 164: 315–320

    Article  CAS  PubMed  Google Scholar 

  5. Ngan BY, Nourse J, Cleary ML . Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas Blood 1989 73: 1759–1762

    CAS  PubMed  Google Scholar 

  6. Hillion J, Mecucci C, Aventin A, Leroux D, Wlodarska I, Van Den Berghe H, Larsen CJ . A variant translocation t(2;18) in follicular lymphoma involves the 5′ end of bcl-2 and Ig kappa light chain gene Oncogene 1991 6: 169–172

    CAS  PubMed  Google Scholar 

  7. Buchonnet G, Lenain P, Ruminy P, Lepretre S, Stamatoullas A, Parmentier F, Jardin F, Duval C, Tilly H, Bastard C . Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3′ BCL2 breakpoints and evidence of a new cluster Leukemia 2000 14: 1563–1569

    Article  CAS  PubMed  Google Scholar 

  8. Willis TG, Jadayel DM, Coignet LJ, Abdul-Rauf M, Treleaven JG, Catovsky D, Dyer MJ . Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction Blood 1997 90: 2456–2564

    CAS  PubMed  Google Scholar 

  9. Akasaka T, Akasaka H, Yonetani N, Ohno H, Yamabe H, Fukuhara S, Okuma M . Refinement of the BCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets Genes Chromosomes Cancer 1998 21: 17–29

    Article  CAS  PubMed  Google Scholar 

  10. Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfield CD . Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma Ann Intern Med 1988 108: 14–20

    Article  CAS  PubMed  Google Scholar 

  11. Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit M, Bastard C . Prognostic value of chromosomal abnormalities in follicular lymphoma Blood 1994 84: 1043–1049

    CAS  PubMed  Google Scholar 

  12. Lopez-Guillermo A, Cabanillas F, McDonnell TI, McLaughlin P, Smith T, Pugh W, Hagemeister F, Rodriguez MA, Romaguera JE, Younes A, Sarris AH, Preti HA, Lee MS . Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma Blood 1999 93: 3081–3087

    CAS  PubMed  Google Scholar 

  13. Jager U, Bocskor S, Le T, Mitterbauer G, Bolz I, Chott A, Kneba M, Mannhalter C, Nadel B . Follicular lymphomas’ BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation Blood 2000 95: 3520–3529

    CAS  PubMed  Google Scholar 

  14. Welzel N, Le T, Marculescu R, Mitterbauer G, Chott A, Pott C, Kneba M, Du MQ, Kusec R, Drach J, Raderer M, Mannhalter C, Lechner K, Nadel B, Jaeger U . Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma Cancer Res 2001 61: 1629–1636

    CAS  PubMed  Google Scholar 

  15. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD . World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting – Airlie House, Virginia, November 1997 J Clin Oncol 1999 17: 3835–3849

    Article  CAS  PubMed  Google Scholar 

  16. Tilly H, Bastard C, Delastre T, Duval C, Bizet M, Lenormand B, Dauce JP, Monconduit M, Piguet H . Cytogenetic studies in untreated Hodgkin's disease Blood 1991 77: 1298–1304

    CAS  PubMed  Google Scholar 

  17. Mitelman F (ed). An International System For Human Cytogenetic Nomenclature S Karger: Basel 1995

    Google Scholar 

  18. Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA, van Wering ER, van Dongen JJ, van der Schoot CE . Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia Leukemia 2000 14: 1426–1435

    Article  CAS  PubMed  Google Scholar 

  19. Kaplan EL, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457–481

    Article  Google Scholar 

  20. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG . Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples Br J Cancer 1977 35: 1–39

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rothman KJ . Estimation of confidence limits for the cumulative probability of survival in life table analysis J Chronic Dis 1978 31: 557–560

    Article  CAS  PubMed  Google Scholar 

  22. Horsman DE, Gascoyne RD, Coupland RW, Coldman AJ, Adomat SA . Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma Am J Clin Pathol 1995 103: 472–478

    Article  CAS  PubMed  Google Scholar 

  23. Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, Rovera G . Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes J Exp Med 1991 173: 395–407

    Article  CAS  PubMed  Google Scholar 

  24. Brezinschek HP, Brezinschek RI, Lipsky PE . Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction J Immunol 1995 155: 190–202

    CAS  PubMed  Google Scholar 

  25. Wyatt RT, Rudders RA, Zelenetz A, Delellis RA, Krontiris TG . BCL2 oncogene translocation is mediated by a chi-like consensus J Exp Med 1992 175: 1575–1588

    Article  CAS  PubMed  Google Scholar 

  26. Stamatopoulos K, Kosmas C, Belessi C, Stavroyianni N, Kyriazopoulos P, Papadaki T . Molecular insights into the immunopathogenesis of follicular lymphoma Immunol Today 2000 21: 298–305

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Comité Départemental de Seine-Maritime de la Ligue Nationale Française Contre le Cancer.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buchonnet, G., Jardin, F., Jean, N. et al. Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?. Leukemia 16, 1852–1856 (2002). https://doi.org/10.1038/sj.leu.2402568

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402568

Keywords

This article is cited by

Search

Quick links